Page last updated: 2024-12-07

sulfosuccinimidyl acetate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

sulfosuccinimidyl acetate: inhibits Rubisco activase [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID127857
SCHEMBL ID1109018
MeSH IDM0233506

Synonyms (21)

Synonym
sodium 1-acetoxy-2,5-dioxopyrrolidine-3-sulfonate
sulfosuccinimidyl acetate
1-acetyloxy-2,5-dioxopyrrolidine-3-sulfonic acid
1-(acetyloxy)-2,5-dioxo-3-pyrrolidinesulfonic acid
sulfosuccinimidyl-acetate
3-pyrrolidinesulfonic acid, 1-(acetyloxy)-2,5-dioxo-
3-sulfosuccinimid-1-yl acetate
sulfo-nhs-acetate
152305-87-8
AKOS015893045
1-acetoxy-2,5-dioxopyrrolidine-3-sulfonic acid
SCHEMBL1109018
1-acetoxy-2,5-dioxo-3-pyrrolidinesulfonic acid
sulphosuccinimidyl acetate
mfcd01861959
1-(acetyloxy)-2,5-dioxopyrrolidine-3-sulfonic acid
DTXSID90934466
C70128
CS-0115871
HY-140341
1-acetoxy-2,5-dioxopyrrolidine-3-sulfonicacid
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (7)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's2 (28.57)18.2507
2000's3 (42.86)29.6817
2010's2 (28.57)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.24

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.24 (24.57)
Research Supply Index2.08 (2.92)
Research Growth Index4.32 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.24)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other7 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]